P-271Efficacy and tolerability of the combination of Liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic cancers: post-approval clinic experience. (2nd July 2019) - Paluri, R; Kasi, A; Mcginnis, T; Smith, C; Williams, G; Jacob, R; Manne, U; Gbolahan, O; Naik, G